Gerrard Herro

University of Minnesota Medical Center

Papers

1

Total Citations

41

H-Index

1

About

Dr. Gerrard Herro is a biochemist whose research has significantly advanced the understanding of glycosaminoglycan (GAG) metabolism, particularly in the context of human disease and global diagnostics. His most cited work, a 2002 study on urinary GAG excretion, introduced an automated semimicro method that enabled reliable quantification of these biomarkers from specimens transported worldwide. This innovation, cited over 40 times, has been instrumental in improving the screening and monitoring of mucopolysaccharidoses and other lysosomal storage disorders, making diagnostic testing more accessible across diverse geographic settings. Dr. Herro’s contributions lie at the intersection of analytical chemistry and clinical biochemistry, where his methodological developments have enhanced the precision and practicality of metabolic disease detection. His work underscores a commitment to bridging laboratory science with real-world clinical needs, particularly in resource-limited environments. By refining techniques for GAG analysis, he has provided a foundation for subsequent research into disease progression and therapeutic efficacy, solidifying his role as a key figure in the field of inherited metabolic disorders.

Research Focus

Key Achievements

1
H-Index
1
Papers
41
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Urinary Glycosaminoglycan Excretion Quantified by an Automated Semimicro Method in Specimens Conveniently Transported from Around the Globe
41 citations · 2002
📈 Most Prolific Year: 2002 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: University of Minnesota Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago